Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The epigenetic life cycle of epstein–barr virus.
Curr. Top. Microbiol. Immunol. 390, 103-117 (2015)
Ever since the discovery of Epstein–Barr virus (EBV) more than 50 years ago, this virus has been studied for its capacity to readily establish a latent infection, which is the prominent hallmark of this member of the herpesvirus family. EBV has become an important model for many aspects of herpesviral latency, but the molecular steps and mechanisms that lead to and promote viral latency have only emerged recently. It now appears that the virus exploits diverse facets of epigenetic gene regulation in the cellular host to establish a latent infection. Most viral genes are transcriptionally repressed, and viral chromatin is densely compacted during EBV’s latent phase, but latent infection is not a dead end. In order to escape from this phase, epigenetic silencing must be reverted efficiently and quickly. It appears that EBV has perfected a clever strategy to overcome transcriptional repression of its many lytic genes to initiate virus de novo synthesis within a few hours after induction of its lytic cycle. This review tries to summarize the known molecular mechanisms, the current models, concepts, and ideas underlying this viral strategy. This review also attempts to identify and address gaps in our current understanding of EBV’s epigenetic mechanisms within the infected cellular host.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Dna Methylation ; Epigenetics ; Pioneer Factor ; Reprogramming ; Transcription; B-cell Transformation; Viral Genome; Epithelial-cells; Dna-replication; Initial-stages; Gene Promoter; Lytic Switch; Infection; Latent; Methylation
ISSN (print) / ISBN
0070-217x
e-ISSN
0070-217X
Konferenztitel
Epstein Barr Virus Volume 1 : One Herpes Virus: Many Diseases
Zeitschrift
Current Topics in Microbiology and Immunology
Quellenangaben
Band: 390,
Seiten: 103-117
Verlag
Springer
Verlagsort
Berlin ; Heidelberg [u.a.]
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Gene Vector (AGV)